FDA panel recommends against MoM hip implants but stops short of withdrawal
This article was originally published in Clinica
Executive Summary
A US FDA panel has questioned the continued use of metal-on-metal (MoM) hip implants; however, the panellists did not go so far as to recommend withdrawing the devices from the market.